Follow last change Dec 2022 re-read 3 minutes ago

LSD

Developed for: major depressive disorder
Investigated by: Department of Psychiatry Basel (UPK Basel; Prof. Dr. med. Stefan Borgwardt) · University Hospital, Basel, Switzerland

today NCT03866252 · Ph 2

2020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT03866252	Nov 2019 → Sep 2022	major depressive disorder	University Hospital, Basel, Switzerland	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	LSD	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03866252 ↗
Route	Oral	“LSD administration per os” NCT03866252 ↗